Consistent with the in vitro data, a decrease in the rate of PCNA‐positive tumor cells and an increase in that of cleaved caspase‐3‐positive cells and melanin‐positive cells were observed in trabectedin‐treated CCS xenograft tumors (Fig. 5B). This evidence concerns the gene PCNA and neoplasm.